Market revenue in 2022 | USD 787.9 million |
Market revenue in 2030 | USD 1,199.1 million |
Growth rate | 5.4% (CAGR from 2022 to 2030) |
Largest segment | Estrogen and progesterone replacement therapy |
Fastest growing segment | Parathyroid Hormone replacement |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Estrogen and Progesterone Replacement Therapy, HGH replacement therapy, Thryoid hormone replacement therapy, Testosterone Replacement Therapy, Parathyroid Hormone replacement |
Key market players worldwide | Eli Lilly and Co, Bayer AG, Hisamitsu Pharmaceutical Co Inc, Pfizer Inc, Merck & Co Inc, Viatris Inc, Novo Nordisk A/S ADR, AbbVie Inc, Roche Holding AG ADR, Ascend Wellness Holdings Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hormone replacement therapy market will help companies and investors design strategic landscapes.
Estrogen and progesterone replacement therapy was the largest segment with a revenue share of 57.8% in 2022. Horizon Databook has segmented the Middle East & Africa hormone replacement therapy market based on estrogen and progesterone replacement therapy, hgh replacement therapy, thryoid hormone replacement therapy, testosterone replacement therapy, parathyroid hormone replacement covering the revenue growth of each sub-segment from 2018 to 2030.
Middle Eastern countries, such as Saudi Arabia, Qatar, UAE, Kuwait, and Oman, are prospering economies. Advancements in healthcare systems are expected t o increase the demand for hormonal replacement drugs in this region.
In coordination with WHO or other independent organizations, governments of these countries are undertaking several initiatives for the advancement of healthcare sector in the region. This is expected to help in the development of the market in the near future.
These regions face issues of social stigma and lack of healthcare infrastructure, which is also expected to restrain the regional hormonal replacement therapy market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa hormone replacement therapy market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa hormone replacement therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account